Skip to content

Nurix Therapeutics, Inc. NRIX Brisbane, California — Operating lease, liability

Similar metrics at other companies

The Vita Coco Company, Inc. logo
COCOLease liability
$3.13M+975%
WSFS Financial logo
WSFSLease liabilities
$26.31M-17.8%
Super Micro Computer, Inc. logo
SMCISan Jose, California — Operating lease, liability
$14.3M
Sylvamo logo
SLVMLease, Liability
$75M-7.4%
Macerich logo
MACLease liabilities
$65.15M-0.5%
Banner Corporation logo
BANRLease liability
$8.59M-17.5%

Other financials

Income statement

See full
Revenue$6.3M-66.1%
Operating income-$92.5M-47.1%
Net income-$87.2M-54.7%
EPS (diluted)-$0.79-17.9%

Balance sheet

See full
Cash & equivalents$72.2M-6.1%
Total debt$58.7M+120%
Total equity$480.9M0.0%
Total assets$636.1M+3.4%

Cash flow

See full
Operating cash flow-$71.9M-17.7%
CapEx$1.0M-70.0%
Free cash flow-$73.0M-13.0%

Valuation

See full
Market cap$1.95B+40.1%
Enterprise value$1.94B+45.1%
P/S27.2×+2.5×

Profitability

See full
Operating margin-439.3%+35.3pp
Net margin-411.4%+52.7pp
FCF margin-378.7%+24.1pp

Returns & leverage

See full
Return on equity-61.4%-2.5pp
Debt / equity0.1×+0.1×
Current ratio-0.3×

Where this comes from

Reported directly by Nurix Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.

The official record: Nurix Therapeutics, Inc.’s 10-K, filed January 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nurix Therapeutics, Inc.'s brisbane, california — operating lease, liability.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nurix Therapeutics, Inc.'s brisbane, california — operating lease, liability?
Nurix Therapeutics, Inc. (NRIX) reported brisbane, california — operating lease, liability of $5.8M in Q2 2025.
What does brisbane, california — operating lease, liability mean?
This metric quantifies the present value of future lease payments for the Brisbane, California facility, recognized as a financial liability. It represents the company's contractual obligation to make payments over the remaining lease term. Tracking this liability is critical for evaluating the company's fixed financial commitments and overall solvency.